| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | BIODEL INC SHS | 182 | 8,000 | 0.00% | Put | |
| 2 | BIO PATH HOLDINGS INC | 14,873 | 17,000 | 0.00% | ||
| 3 | Apricus Biosciences, Inc. | 12,176 | 18,000 | 0.00% | ||
| 4 | CHINA MOBILE LIMITED | 481 | 19,000 | 0.00% | Call | |
| 5 | XOMA CORP DEL | 500 | 38,000 | 0.00% | Call | |
| 6 | OPEXA THERAPEUTICS INC | 382,765 | 46,000 | 0.00% | ||
| 7 | INTELLIPHARMACEUTICS INTL IN | 187 | 47,000 | 0.00% | Put | |
| 8 | ACELRX PHARMACEUTICALS INC | 172 | 52,000 | 0.00% | Call | |
| 9 | PLURISTEM THERAPEUTICS INC | 292 | 53,000 | 0.00% | Put | |
| 10 | KERYX BIOPHARMACEUTICALS INC | 158 | 56,000 | 0.00% | Put | |
| 11 | ACELRX PHARMACEUTICALS INC | 186 | 57,000 | 0.00% | Put | |
| 12 | ORAMED | 10,558 | 58,000 | 0.00% | ||
| 13 | APRICUS BIOSCIENCES INC | 605 | 88,000 | 0.00% | Put | |
| 14 | CELSION CORPORATION | 546 | 91,000 | 0.00% | Put | |
| 15 | VITAL THERAPIES INC | 250 | 101,000 | 0.00% | Call | |
| 16 | HISTOGENICS CORP | 27,505 | 110,000 | 0.00% | ||
| 17 | ADAPTIMMUNE THERAPEUTICS PLC | 10,004 | 120,000 | 0.00% | ||
| 18 | SANGAMO THERAPEUTICS INC | 215 | 121,000 | 0.00% | Call | |
| 19 | ACTINIUM PHARMACEUTICALS INC | 68,427 | 121,000 | 0.00% | ||
| 20 | ENDOCYTE INC | 26,423 | 121,000 | 0.00% | ||
| 21 | CELSION CORPORATION COM PAR | 76,805 | 128,000 | 0.01% | ||
| 22 | SKYSTAR BIO PHARMACEUTICAL | 147,926 | 141,000 | 0.01% | ||
| 23 | BENITEC BIOPHARMA LTD | 391,826 | 143,000 | 0.01% | ||
| 24 | HEAT BIOLOGICS INC | 32,201 | 149,000 | 0.01% | ||
| 25 | INSPIREMD INC | 927,876 | 153,000 | 0.01% | ||
| 26 | VITAL THERAPIES INC | 38,700 | 156,000 | 0.01% | ||
| 27 | EXELIXIS INC | 280 | 157,000 | 0.01% | Put | |
| 28 | OCULAR THERAPEUTIX INC | 115 | 162,000 | 0.01% | Call | |
| 29 | MANNKIND CORP. | 53,800 | 173,000 | 0.01% | ||
| 30 | PERSEON CORP | 569,985 | 177,000 | 0.01% | ||
| 31 | APPLIED DNA SCIENCES INC | 63,310 | 196,000 | 0.01% | ||
| 32 | Eyegate Pharmaceuticaals | 200,000 | 204,000 | 0.01% | ||
| 33 | VALEANT PHARMACEUTICALS INTL | 1,171 | 209,000 | 0.01% | ||
| 34 | LPATH INC | 1,086,171 | 213,000 | 0.01% | ||
| 35 | PEREGRINE PHARMACEUTICALS IN | 10,907 | 215,000 | 0.01% | ||
| 36 | AMARIN CORP PLC | 1,118 | 216,000 | 0.01% | Put | |
| 37 | CASI PHARMACEUTICALS INC COM | 202,536 | 217,000 | 0.01% | ||
| 38 | IMMUNE DESIGN CORP | 20,000 | 244,000 | 0.01% | ||
| 39 | MACROGENICS INC | 114 | 244,000 | 0.01% | Call | |
| 40 | AVALANCHE BIOTECHNOLOGIES IN | 300 | 247,000 | 0.01% | Put | |
| 41 | CELLDEX THERAPEUTICS INC NEW | 238 | 251,000 | 0.01% | Put | |
| 42 | INFINITY PHARMACEUTICALS INC | 300 | 254,000 | 0.01% | Put | |
| 43 | INFINITY PHARMACEUTICALS INC | 30,000 | 254,000 | 0.01% | ||
| 44 | BIOLASE INC | 283,231 | 255,000 | 0.01% | ||
| 45 | BIODELIVERY SCIENCES INTL IN | 458 | 255,000 | 0.01% | Call | |
| 46 | NEURODERM LTD | 12,416 | 257,000 | 0.01% | ||
| 47 | ALKERMES PLC | 537 | 260,000 | 0.01% | Call | |
| 48 | RAPTOR PHARMACEUTICAL CORP | 436 | 264,000 | 0.01% | Put | |
| 49 | Axovant Sciences LTD | 21,053 | 272,000 | 0.01% | ||
| 50 | Pieris Pharmaceuticals | 150,708 | 276,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-065626, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
